Impact of asymptomatic


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
23 07 2021
Historique:
received: 26 03 2021
accepted: 20 07 2021
pubmed: 24 7 2021
medline: 21 10 2021
entrez: 23 7 2021
Statut: epublish

Résumé

Asymptomatic In a 29-month cohort of 268 people in Western Kenya, we investigated the association between asymptomatic Compared to being uninfected, asymptomatic infections were associated with an increased 1 month likelihood of symptomatic malaria (adjusted hazard ratio [aHR]: 2.61, 95% CI: 2.05 to 3.33), and this association was modified by sex, with females (aHR: 3.71, 95% CI: 2.62 to 5.24) at higher risk for symptomaticity than males (aHR: 1.76, 95% CI: 1.24 to 2.50). This increased symptomatic malaria risk was observed for asymptomatic infections of all densities and in people of all ages. Long-term risk was attenuated but still present in children under age 5 (29-month aHR: 1.38, 95% CI: 1.05 to 1.81). In this high-transmission setting, asymptomatic This work was supported by the National Institute of Allergy and Infectious Diseases (R21AI126024 to WPO, R01AI146849 to WPO and SMT).

Sections du résumé

Background
Asymptomatic
Methods
In a 29-month cohort of 268 people in Western Kenya, we investigated the association between asymptomatic
Results
Compared to being uninfected, asymptomatic infections were associated with an increased 1 month likelihood of symptomatic malaria (adjusted hazard ratio [aHR]: 2.61, 95% CI: 2.05 to 3.33), and this association was modified by sex, with females (aHR: 3.71, 95% CI: 2.62 to 5.24) at higher risk for symptomaticity than males (aHR: 1.76, 95% CI: 1.24 to 2.50). This increased symptomatic malaria risk was observed for asymptomatic infections of all densities and in people of all ages. Long-term risk was attenuated but still present in children under age 5 (29-month aHR: 1.38, 95% CI: 1.05 to 1.81).
Conclusions
In this high-transmission setting, asymptomatic
Funding
This work was supported by the National Institute of Allergy and Infectious Diseases (R21AI126024 to WPO, R01AI146849 to WPO and SMT).

Identifiants

pubmed: 34296998
doi: 10.7554/eLife.68812
pii: 68812
pmc: PMC8337072
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI146849
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI126024
Pays : United States

Informations de copyright

© 2021, Sumner et al.

Déclaration de conflit d'intérêts

KS, JM, AO, EF, LA, SM, JE, BP, WP, ST No competing interests declared

Références

Malar J. 2015 Feb 18;14:83
pubmed: 25880427
J Infect Dis. 2020 Mar 16;221(7):1176-1184
pubmed: 31665350
Malar J. 2016 Feb 09;15:77
pubmed: 26861943
Sci Rep. 2020 Oct 30;10(1):18740
pubmed: 33127922
Am J Trop Med Hyg. 2019 Dec;101(6):1416-1423
pubmed: 31674301
Malar J. 2016 Nov 14;15(1):553
pubmed: 27842542
Lancet Infect Dis. 2018 May;18(5):565-572
pubmed: 29398388
Elife. 2020 Oct 27;9:
pubmed: 33107430
Parasitology. 2004 Mar;128(Pt 3):235-43
pubmed: 15074873
Epidemiology. 2010 Jan;21(1):13-5
pubmed: 20010207
Clin Infect Dis. 2018 Jun 1;66(12):1883-1891
pubmed: 29304258
Clin Infect Dis. 2021 Apr 27;:
pubmed: 33904907
J Infect Dis. 2004 Jun 15;189(12):2220-6
pubmed: 15181569
Stat Methods Med Res. 2013 Feb;22(1):70-96
pubmed: 22016461
PLoS One. 2011 Feb 24;6(2):e16940
pubmed: 21383984
Trans R Soc Trop Med Hyg. 2004 Dec;98(12):687-94
pubmed: 15485698
Clin Infect Dis. 2017 Mar 1;64(5):645-653
pubmed: 28362910
Mayo Clin Proc. 2020 Nov;95(11):2408-2419
pubmed: 33153631
Malar J. 2013 Jul 03;12:227
pubmed: 23822192
Clin Infect Dis. 2015 May 15;60(10):1481-8
pubmed: 25694651
Am J Trop Med Hyg. 1995 Jun;52(6):565-8
pubmed: 7611566
Malar J. 2015 Jan 05;14:7
pubmed: 25559587
Epidemiology. 2008 Nov;19(6):766-79
pubmed: 18854702
J Infect Dis. 2019 Feb 23;219(6):936-944
pubmed: 30307567
Clin Infect Dis. 2008 Feb 15;46(4):516-22
pubmed: 18199040
Malar J. 2014 Apr 02;13:132
pubmed: 24690179
Malar J. 2008 Sep 29;7:193
pubmed: 18823542
Nature. 2017 Oct 26;550(7677):515-518
pubmed: 29019978
Trop Med Int Health. 2004 Aug;9(8):862-8
pubmed: 15303990
PLoS One. 2011 Jan 31;6(1):e16420
pubmed: 21305011
J Infect Dis. 2015 Aug 15;212(4):608-16
pubmed: 25712968
Clin Infect Dis. 2019 Jan 1;68(1):106-112
pubmed: 29788054

Auteurs

Kelsey M Sumner (KM)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Division of Infectious Diseases, School of Medicine, Duke University, Durham, United States.

Judith N Mangeni (JN)

School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.

Andrew A Obala (AA)

School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.

Elizabeth Freedman (E)

Division of Infectious Diseases, School of Medicine, Duke University, Durham, United States.

Lucy Abel (L)

Academic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya.

Steven R Meshnick (SR)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.

Jessie K Edwards (JK)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.

Brian W Pence (BW)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.

Wendy Prudhomme-O'Meara (W)

Division of Infectious Diseases, School of Medicine, Duke University, Durham, United States.
School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.
Duke Global Health Institute, Duke University, Durham, United States.

Steve M Taylor (SM)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.
Division of Infectious Diseases, School of Medicine, Duke University, Durham, United States.
Duke Global Health Institute, Duke University, Durham, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH